Evidence map›Paper›PMID 26398225›Full record

ArticleChemical research in toxicology2015

Comprehensive High-Resolution Mass Spectrometric Analysis of DNA Phosphate Adducts Formed by the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Bin Ma, Peter W Villalta, Adam T Zarth, Delshanee Kotandeniya, Pramod Upadhyaya, Irina Stepanov, Stephen S Hecht

Open access · greenAbstract read
In one paragraph

Article in Chemical research in toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. 5-(Pyridin-3-yl)-3,4-dihydro-2Royal Society open science · 2024
    Article
  3. Article
  4. DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways.International journal of molecular sciences · 2023
    Review
  5. Article
  6. LC-MS/MS for Assessing the Incorporation and Repair ofChemical research in toxicology · 2022
    Article
  7. Article
  8. Metabolism and DNA Adduct Formation of Tobacco-SpecificInternational journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Identification of anChemical research in toxicology · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bin MaMasonic Cancer Center, University of Minnesota , 2231 6th St SE, Minneapolis, Minnesota 55455, United States.
Peter W VillaltaMasonic Cancer Center, University of Minnesota , 2231 6th St SE, Minneapolis, Minnesota 55455, United States.
Adam T ZarthMasonic Cancer Center, University of Minnesota , 2231 6th St SE, Minneapolis, Minnesota 55455, United States.
Delshanee KotandeniyaMasonic Cancer Center, University of Minnesota , 2231 6th St SE, Minneapolis, Minnesota 55455, United States.
Pramod UpadhyayaMasonic Cancer Center, University of Minnesota , 2231 6th St SE, Minneapolis, Minnesota 55455, United States.
Irina StepanovMasonic Cancer Center, University of Minnesota , 2231 6th St SE, Minneapolis, Minnesota 55455, United States.
Stephen S HechtMasonic Cancer Center, University of Minnesota , 2231 6th St SE, Minneapolis, Minnesota 55455, United States.
University of Minnesota · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
METABOLISM OF CARCINOGENIC TOBACCO SPECIFIC NITROSAMINESR01CA081301 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI STEPHEN S HECHT · 1999 to 2026
$7.1M
Metabolism of Carcinogenic Tobacco-Specific NitrosaminesR37CA081301 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HECHT, STEPHEN S · 2004 to 2013
$5.5M
NCI NIH HHS CA-77598NCI NIH HHS CA-81301NCI NIH HHS R01 CA081301
6 · The paper itself

Abstract

The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK, 1) is a potent lung carcinogen in laboratory animals and is believed to play a key role in the development of lung cancer in smokers. Metabolic activation of NNK leads to the formation of pyridyloxobutyl DNA adducts, a critical step in its mechanism of carcinogenesis. In addition to DNA nucleobase adducts, DNA phosphate adducts can be formed by pyridyloxobutylation of the oxygen atoms of the internucleotidic phosphodiester linkages. We report the use of a liquid chromatography-nanoelectrospray ionization-high-resolution tandem mass spectrometry technique to characterize 30 novel pyridyloxobutyl DNA phosphate adducts in calf thymus DNA (CT-DNA) treated with 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone (NNKOAc, 2), a regiochemically activated form of NNK. A (15)N3-labeled internal standard was synthesized for one of the most abundant phosphate adducts, dCp[4-oxo-4-(3-pyridyl)butyl]dC (CpopC), and this standard was used to quantify CpopC and to estimate the levels of other adducts in the NNKOAc-treated CT-DNA. Formation of DNA phosphate adducts by NNK in vivo was further investigated in rats treated with NNK acutely (0.1 mmol/kg once daily for 4 days by subcutaneous injection) and chronically (5 ppm in drinking water for 10, 30, 50, and 70 weeks). This study provides the first comprehensive structural identification and quantitation of a panel of DNA phosphate adducts of a structurally complex carcinogen and chemical support for future mechanistic studies of tobacco carcinogenesis in humans.

Indexed as

DNA AdductsAnimalsCarcinogensDNALungLung NeoplasmsMaleNitrosaminesPhosphatesRats, Inbred F344Spectrometry, Mass, Electrospray IonizationTandem Mass Spectrometry4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneCarcinogensDNADNA AdductsNitrosaminesPhosphates

Identifiers

PMID26398225
PMCPMC4652278
OpenAlexW2238435888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.